Monopar Therapeutics
MNPR
#7582
Rank
S$0.62 B
Marketcap
S$92.69
Share price
-0.94%
Change (1 day)
-6.60%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): S-$2.46

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.46. In 2025 the company made an earnings per share (EPS) of S-$2.38 an increase over its 2024 EPS that were of S-$5.29.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.463.18%
2025S-$2.38-54.99%
2024S-$5.2935.2%
2023S-$3.91-26.75%
2022S-$5.3413.7%
2021S-$4.7025.86%
2020S-$3.7328.89%
2019S-$2.9045.28%
2018S-$1.99-80.5%
2017S-$10.231296.33%
2016S-$0.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA